NEW YORK, Sept. 23, 2016 /PRNewswire/ -- Columbia Care LLC ("CC"), a leading national medical marijuana company, announced today that it was selected as a licensee to grow and dispense medical marijuana, and derivative medicines, to qualifying patients in the State of Delaware. Following a competitive application process, Columbia Care was selected and awarded one of only two additional, highly coveted, fully integrated licenses. This brings the total number of licensed operators in Delaware to two with a third expected to be awarded later on this year. Both the Company's cultivation and manufacturing facility and its pharmacy, known in Delaware as a Compassion Center, are projected to open in Kent County in the second half of 2017.
"Our organization is delighted and honored to be selected as one of Delaware's operators. On behalf of our Delaware-based team and the entire national organization, we are so thankful for this opportunity and privilege. We commit to work tirelessly with all of Delaware's stakeholders to provide access to the highest quality medicine and customer service," said Columbia Care CEO Nicholas Vita. "As the first state to ratify the Constitution, Delaware has a storied history of demonstrating national leadership while maintaining its unique sense of community. We will endeavor to contribute to the fabric of the First State and improve the lives of qualifying patients. Our deepest thanks to all stakeholders for their support including the Governor, Secretary, Department, Administrators, Legislature, Senators, Congressmen and all of the individuals who have given us this honor and opportunity. Go Blue Hens!"
Consistent with the Company's national, medically-focused operating model, Columbia Care's Compassion Center in Delaware will be designed and operated with patient comfort and safety as the top priorities. The Compassion Center will be staffed by a dedicated team trained to provide the highest level of professionalism, compassion, confidentiality and respect for patients and their medical conditions. All aspects of safety and security in both facilities will be provided by professionals with law enforcement backgrounds utilizing industry-leading security measures. For more information about Columbia Care Delaware, please visit www.col-carede.com.
Delaware is the seventh jurisdiction in the United States where Columbia Care has been approved to cultivate, manufacture and dispense cannabinoid-based medicines and products. For more information on the Delaware Medical Marijuana Program, including information on how to register, please visit http://dhss.delaware.gov/dhss/dph/hsp/medmarhome.html.
About Columbia Care LLC
Columbia Care is one of the nation's largest and most experienced manufacturers and providers of medical marijuana products and services. The Company is licensed in highly selective and regulated jurisdictions and has completed more than 450,000 successful patient interactions since its inception. Founded by two former Goldman Sachs executives, and working in collaboration with some of the most renowned and innovative teaching hospitals and medical centers in the country, Columbia Care is a patient-centered healthcare company setting the standards for compassion, professionalism, quality, caring, and innovation for a burgeoning new industry.
For more information on Columbia Care, please visit www.col-care.com.
SOURCE Columbia Care